New cream shows promise for rare skin disorder
NCT ID NCT06137157
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 30 times
Summary
This early-stage study tests a new cream called ATR12-351 in 12 adults with Netherton Syndrome, a rare genetic skin condition. The cream is applied to skin lesions twice daily for two weeks, with a placebo cream used on other areas for comparison. The main goals are to check safety and see if the cream improves skin symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NETHERTON SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGPalo Alto, California, 94304, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Yale University
COMPLETEDNew Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.